Number with incontinence not improved (women's observations) ‐ Oestrogen vs PPA · patients with urinary incontinence in post‐menopausal women
Oestrogen showed no clear difference in number with incontinence not improved (women's observations) ‐… compared with other treatments (moderate certainty).
1 finding from 1 review
Adverse effects ‐ oestrogen vs PPA · patients with urinary incontinence in post‐menopausal women
1 finding from 1 review
Improvement in symptoms (participant‐assessed) (oestrogen ring vs oestrogen cream) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in improvement in symptoms (participant‐assessed) (oestrogen ring vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (participant‐assessed) (oestrogen ring vs oestrogen tablets) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in improvement in symptoms (participant‐assessed) (oestrogen ring vs… compared with other regimens (low certainty).
1 finding from 1 review
Endometrial thickness (mm) · postmenopausal women with vaginal atrophy
Oestrogen ring may leads to lower endometrial thickness (oestrogen ring vs oestrogen cream) compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen ring vs oestrogen cream) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in improvement in symptoms (clinician‐assessed) (oestrogen ring vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen ring vs oestrogen tablets) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in improvement in symptoms (clinician‐assessed) (oestrogen ring vs… compared with other regimens (low certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen ring vs oestrogen cream) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs oestrogen… compared with other regimens (low certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs placebo) compared with other regimens (moderate certainty).
1 finding from 1 review
Improvement in symptoms (participant‐assessed) (oestrogen cream vs isoflavone gel) · postmenopausal women with vaginal atrophy
Oestrogen cream showed no clear difference in improvement in symptoms (participant‐assessed) (oestrogen cream vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (participant‐assessed) oestrogen cream vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen cream may leads to higher improvement in symptoms (participant‐assessed) oestrogen cream vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen cream vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen cream may leads to higher improvement in symptoms (clinician‐assessed) (oestrogen cream vs… compared with other regimens (low certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen cream showed no clear difference in adverse events (total adverse events) (oestrogen cream vs… compared with other regimens (low certainty).
1 finding from 1 review
Endometrial thickness (mm) · postmenopausal women with vaginal atrophy
Oestrogen tablets showed no clear difference in endometrial thickness (oestrogen tablets vs oestrogen cream) compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen tablets vs oestrogen cream) · postmenopausal women with vaginal atrophy
Oestrogen tablets showed no clear difference in improvement in symptoms (clinician‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen tablets vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen tablets may leads to higher improvement in symptoms (clinician‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen tablets showed no clear difference in adverse events (total adverse events) (oestrogen tablets vs placebo) compared with other regimens (moderate certainty).
1 finding from 1 review
Improvement in symptoms (participant‐assessed) (oestrogen cream vs isoflavone gel) · postmenopausal women with vaginal atrophy
Oestrogen tablets showed no clear difference in improvement in symptoms (participant‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (participant‐assessed) (oestrogen tablets vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen tablets may leads to higher improvement in symptoms (participant‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
1 finding from 1 review
Live birth or ongoing pregnancy · ovarian stimulation protocols for women undergoing ART
Oestrogen showed no clear difference in live birth or ongoing pregnancy (Oestr + Ant vs Ant) compared with no pretreatment (moderate certainty).
2 findings from 1 review